Eczema is found to be an immune-driven disease.
Researchers at the Icahn School of Medicine at Mount Sinai, New York, discovered atopic dermatitis (eczema) to be an immune-driven disease at the molecular level. Only revealed in 2014, this research offers an upgrade to the understanding and treatment associated with healing from eczema.
Eczema is now classified similar to Psoriasis, in that the body’s immune system aims to attack invading viruses, but instead mistakenly attacks bodily tissues, such as the skin. This inflammatory and incredibly itchy condition can cover much of the body in lesions, leaving it susceptible to infection. What was once suggested to be a genetic and environmental condition, has now been reclassified.Link to Mount Sinai Research